Sector: Life Sciences

Latest content

UPC appeal court overturns injunction in huge boost for bankrupt NanoString

First appellate PI decision comes as first instance judges largely opt to rule against preliminary sales bans

27 February 2024

mRNA firms and other biopharma patentees dominate ‘Innovation Momentum’ rankings

Newly released report throws light on which life sciences companies have the most dynamic IP portfolios

22 February 2024

mRNA trade secrets to become even more important, says WHO vaccine hub boss

IAM talked with Petro Terblanche, CEO of Afrigen Biologics, about the WHO vaccine hub and its IP strategy

21 February 2024

Delhi High Court backpedals in landmark pharma ruling on product-by-process claims

Reversal in favour of Vifor is a boon for innovators

20 February 2024

Alexion injunction against Amgen overturned in landmark Munich appeal

Reversal has major implications for future disputes involving rare disease treatments

12 February 2024

NanoString bankrupted by patent litigation, with major ramifications for ongoing 10x dispute

Everything you need to know about how the Chapter 11 process impacts the companies’ high-profile spat

08 February 2024

Pandemic-era patent applications have levelled off a downturn in US grants

Anaqua AcclaimIP's analysis found that US companies, which earn the most US patents, increased their number of 2023 patents by 18% year-over-year

07 February 2024

Successful Novartis appeal provides critical clarification on India’s pre-grant opposition process

A Delhi High Court decision has highlighted that the pre-grant process can be abused by parties attempting to derail applications. The division bench has clearly distinguished between the examination and opposition processes, which should streamline the handling of pre-grant oppositions while safeguarding the interests of both sides.

07 February 2024

Turkish court hands down precedential decision on partial preliminary injunctions in pharma dispute

Ruling on the condition of plausible proof, the Ankara IP Court has clarified that an injunction can be granted in a way that prevents damages for both parties. This is especially crucial for cases in which the infringing product is put on the market without waiting for an expert report.

07 February 2024

European Parliament to vote on shock proposal to ban CRISPR-developed plant patents

Patenting prohibition would have significant consequences for agri-tech innovators – and not just in the EU

06 February 2024

Unlock unlimited access to all IAM content